Texas AG sues Pfizer over quality-control lapses in kids' ADHD drug
Texas Attorney General Ken Paxton accused Pfizer and its supplier Tris Pharma of providing children's ADHD medicine that it knew might be ineffective to the state's Medicaid insurance program for l...
Pfizer Stock: Cheap But Will Remain Cheap, For Now
When I saw Pfizer Inc. stock settling below pre-pandemic levels, I knew the deterioration of investor sentiment has a lot to do with declining Covid vaccine sales. This was expected. A deep dive in...
Pfizer's (PFE) New Products May Drive Long-Term Sales Growth
Though Pfizer's (PFE) revenues from COVID products are declining sharply, the launch of some key non-COVID products in 2023 is expected to drive long-term sales and profit growth.
Pfizer to halve UK workforce at Discovery Park
Pfizer Inc (NYSE:PFE) has said it will lay off more than half of its employees at a UK-based scientific research centre in Sandwich. The company intends to make cuts to its 940-strong workforce a...
Pfizer Stock Hits 3-Year Low—Down 50% From 2021 Peak
Excluding a brief early 2020 plunge, Pfizer shares are now trading at their lowest level since 2016.
Pfizer stock dips as Swiss Biotech Basilea secures rights to Fosmanogepix
Swiss biotech Basilea Pharmaceutica (OTC:BPMUF) and Pfizer (NYSE:PFE) subsidiary Amplyx Pharmaceuticals have inked a deal worth $37 million, granting Basilea rights to Fosmanogepix, a Phase 3 ready...
Pfizer wants in on the weight loss drug market – and upcoming data will be crucial for its success
Analysts said upcoming data on Pfizer's obesity pill, danuglipron, will be crucial to how competitive the company can be against Eli Lilly and Novo Nordisk.
High-Quality Dividend Growth Near 52-Week Lows: Pfizer Is Phenomenal
A list of high-quality dividend growth stocks is identified based on proximity to 52-week lows. Pfizer, Bristol-Myers Squibb, ResMed, and NextEra Energy appear attractively valued based on Future a...
Pfizer Inc. (PFE) Presents at Truist Securities BioPharma Symposium (Transcript)
Pfizer Inc. (NYSE:PFE ) Truist Securities BioPharma Symposium November 9, 2023 12:35 PM ET Company Participants Aamir Malik - Executive Vice President and Chief Business Innovation Officer Conferen...
Chart Master: Sell healthcare, hold off on buying Pfizer
Carter Worth, Worth Charting, joins 'Fast Money' to talk his take on the healthcare space, Pfizer's recent performance and more.
Syphilis cases among newborns are skyrocketing, CDC says
The number of babies born with syphilis increased more than 10-fold in the decade ending in 2022, the U.S. Centers for Disease Control and Prevention said Tuesday.
2023 Layoff Tracker: Pfizer Cuts 781 Employees
Hundreds of U.S. companies have slashed their workforces this year, including Amazon, Google, Meta and Disney.
Pfizer and Sanofi shares fall, which one to scoop up?
Pharmaceutical stocks aren't having quite the banner year they've had in the past. Notably, two large pharmaceutical companies recently plunged to 52-week lows on their earnings results.
Valneva to Present and Hold Investor Meetings at the Jefferies London Healthcare Conference
Saint-Herblain (France), November 7, 2023 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that its senior management will present and participate in 1...
Seeking High Dividends? 3 Fairly Valued/Undervalued High Dividend Yield Stocks For Your Portfolio
High dividend yield companies are valuable assets for your portfolio, since they are a great way to generate added income, which you can reinvest or use it to pay your bills. In today's article, I ...
Related Companies